Beneficial effects of empagliflozin on hematocrit levels in a patient with severe anemia

INTRODUCTION: Sodium-glucose cotransporter (SGLT2) inhibitors may additionally benefit patients with diabetes by improving their erythropoiesis followed by the elevation of hemoglobin and hematocrit levels. REASON FOR THE REPORT: In the case described, severe normocytic normochromic anemia was resol...

Descripción completa

Detalles Bibliográficos
Autores principales: Budzianowski, Jan, Rzeźniczak, Janusz, Hiczkiewicz, Jarosław, Kasprzak, Dominika, Winnicka-Zielińska, Anna, Musielak, Bogdan, Pieszko, Konrad, Burchardt, Paweł
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602545/
https://www.ncbi.nlm.nih.gov/pubmed/34545553
http://dx.doi.org/10.1007/s40199-021-00417-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602545/
https://www.ncbi.nlm.nih.gov/pubmed/34545553
http://dx.doi.org/10.1007/s40199-021-00417-5

Ejemplares similares